MK2i also sensitized human breast cancer BT549 and MDA-MB-468 cells to TS (Figures 1G, 1H, S1D, and S1E), implying that MK2 inhibition sensitizes to TNF-induced cell death in general. Here, MAPKAPK2 is linked to breast cancer.